ACKERMANN JEAN has a total of 19 patent applications. Its first patent ever was published in 1907. It filed its patents most often in United States, Switzerland and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are LI YUN-LONG, PHARMACOPEIA LLC and VITAE PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 17 | |
#2 | Switzerland | 1 | |
#3 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Ackermann Jean | 19 |
#2 | Neidhart Werner | 12 |
#3 | Hunziker Daniel | 9 |
#4 | Wertheimer Stanley | 8 |
#5 | Conte Aurelia | 8 |
#6 | Nettekoven Matthias | 8 |
#7 | Kuhn Bernd | 8 |
#8 | Schulz-Gasch Tanja | 6 |
#9 | Aebi Johannes | 5 |
#10 | Maerki Hans-Peter | 5 |
Publication | Filing date | Title |
---|---|---|
US2012041013A1 | Azacyclic compounds | |
US2011257212A1 | Azacyclic derivatives | |
US2011130417A1 | Azacyclic derivatives | |
US2011092512A1 | HSL inhibitors useful in the treatment of diabetes | |
US2011065707A1 | HSL inhibitors useful in the treatment of diabetes | |
US2011028515A1 | Piperidine derivatives | |
US2010292212A1 | Azacyclic derivatives | |
US2010016325A1 | Tetrahydrocinnoline derivatives | |
US2009275573A1 | Imidazolidinone derivatives as 11B-HSD1 inhibitors |